ES2082587T3 - El uso de l-deprenyl para la fabricacion de un medicamento para el tratamiento de la enfermedad de cushing. - Google Patents

El uso de l-deprenyl para la fabricacion de un medicamento para el tratamiento de la enfermedad de cushing.

Info

Publication number
ES2082587T3
ES2082587T3 ES93300476T ES93300476T ES2082587T3 ES 2082587 T3 ES2082587 T3 ES 2082587T3 ES 93300476 T ES93300476 T ES 93300476T ES 93300476 T ES93300476 T ES 93300476T ES 2082587 T3 ES2082587 T3 ES 2082587T3
Authority
ES
Spain
Prior art keywords
deprenyl
manufacture
treatment
medicinal product
cushing disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93300476T
Other languages
English (en)
Inventor
William Woodrow Ruehl
David Stewart Bruyette
David Stevens
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Deprenyl Animal Health Inc
Original Assignee
Deprenyl Animal Health Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Deprenyl Animal Health Inc filed Critical Deprenyl Animal Health Inc
Application granted granted Critical
Publication of ES2082587T3 publication Critical patent/ES2082587T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

SE PONE A DISPOSICION UN METODO DEL TRATAMIENTO DE LA ENFERMEDAD DE CUSHING COMPRENDIENDO EL TRATAMIENTO DE MAMIFEROS, Y ESPECIALMENTE HUMANOS, PERROS, CABALLOS O PONYS CON UNA CANTIDAD DESDE 0,1 HASTA APROXIMADAMENTE 4.0 MG/KG DE PESO DE CUERPO DE L-DEPRENILO, PREFERENTEMENTE EN UN SUMINISTRO DIARIO, PARA ACABAR O MANTENER LA REMISION DE LA ENFERMEDAD.
ES93300476T 1992-03-27 1993-01-22 El uso de l-deprenyl para la fabricacion de un medicamento para el tratamiento de la enfermedad de cushing. Expired - Lifetime ES2082587T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/858,702 US5192808A (en) 1990-08-31 1992-03-27 Therapeutic effect of L-deprenyl in the management of pituitary-dependent hyperadrenocorticism (cushing's disease)

Publications (1)

Publication Number Publication Date
ES2082587T3 true ES2082587T3 (es) 1996-03-16

Family

ID=25328952

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93300476T Expired - Lifetime ES2082587T3 (es) 1992-03-27 1993-01-22 El uso de l-deprenyl para la fabricacion de un medicamento para el tratamiento de la enfermedad de cushing.

Country Status (7)

Country Link
US (1) US5192808A (es)
EP (1) EP0562705B1 (es)
AT (1) ATE128865T1 (es)
DE (1) DE69300608T2 (es)
DK (1) DK0562705T3 (es)
ES (1) ES2082587T3 (es)
GR (1) GR3018657T3 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5561163A (en) * 1990-08-31 1996-10-01 Deprenyl Animal Health, Inc. Treating hearing loss with deprenyl
US5565495A (en) * 1990-08-31 1996-10-15 Deprenyl Animal Health, Inc. Method for survival curve shifting in dogs
CA2039194C (en) * 1990-08-31 1997-01-28 Norton W. Milgram Uses of l-deprenyl and compositions for same
US5817336A (en) * 1993-04-02 1998-10-06 Orion-Yhtyma Oy Composition containing selegiline
DE69425345T2 (de) * 1993-05-04 2001-03-01 Ceva Sante Animale, Libourne Anwendung von Selegilin in Tiermedizin
FR2704756B1 (fr) * 1993-05-04 1995-07-28 Sanofi Elf Utilisation de la sélégiline en médecine vétérinaire.
DE4428444A1 (de) * 1994-08-11 1996-02-15 Dresden Arzneimittel Verwendung von Selegilin zur Behandlung von epileptischen Erkrankungen
US6316022B1 (en) 1995-06-07 2001-11-13 Noven Pharmaceuticals, Inc. Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
WO1996040085A2 (en) * 1995-06-07 1996-12-19 Noven Pharmaceuticals, Inc. Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
ATE219358T1 (de) * 1995-11-06 2002-07-15 Somerset Pharmaceuticals Inc Sublinguale und bukkale verabreichung von selegilin
US6262111B1 (en) 1997-05-21 2001-07-17 Sloan-Kettering Institute For Cancer Research Method for increasing the concentration of ascorbic acid in brain tissues of a subject
WO1998052560A1 (en) 1997-05-21 1998-11-26 Sloan-Kettering Institute For Cancer Research Method for increasing the concentration of ascorbic acid in brain tissues of a subject
US8058442B2 (en) * 2002-11-07 2011-11-15 Technion Research And Development Foundation Ltd. Neuroprotective iron chelators and pharmaceutical compositions comprising them
US8097608B2 (en) * 2003-11-25 2012-01-17 Technion Research And Development Foundation Ltd. Methods for treatment of cardiovascular disorders and diseases
JP2007512319A (ja) * 2003-11-25 2007-05-17 テクニオン リサーチ アンド ディベロップメント ファウンデーション リミテッド 心臓血管障害及び疾患を治療するための組成物及び方法
US8263655B2 (en) * 2005-10-06 2012-09-11 Technion Research And Development Foundation Ltd Methods for treatment of renal failure
RS58988B1 (sr) 2010-02-03 2019-08-30 Pharma Two B Ltd Formulacije razagilina sa produženim oslobađanjem i njegove upotrebe

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA871155A (en) * 1971-05-18 Chinoin Gyogyszer-Es Vegyeszeti Termekek Gyara Rt Optically active phenyl isopropylamine derivatives having pharmaceutical properties and their preparation
HU187775B (en) * 1982-07-14 1986-02-28 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt,Hu New process for producing propargile-amines of pharmaceutical activity
HU193662B (en) * 1983-12-20 1987-11-30 Chinoin Gyogyszer Es Vegyeszet Process for producing synergetic pharmaceutical composition of antidepressive aktivity
US4916151A (en) * 1985-12-05 1990-04-10 Merrell Dow Pharmaceuticals Inc. Method of treating parkinson's syndrome
US4871550A (en) * 1986-09-05 1989-10-03 Millman Phillip L Nutrient composition for athletes and method of making and using the same
US4861800A (en) * 1987-08-18 1989-08-29 Buyske Donald A Method for administering the drug deprenyl so as to minimize the danger of side effects

Also Published As

Publication number Publication date
DE69300608T2 (de) 1996-06-05
GR3018657T3 (en) 1996-04-30
ATE128865T1 (de) 1995-10-15
EP0562705A1 (en) 1993-09-29
EP0562705B1 (en) 1995-10-11
DE69300608D1 (de) 1995-11-16
US5192808A (en) 1993-03-09
DK0562705T3 (da) 1996-02-19

Similar Documents

Publication Publication Date Title
ES2082587T3 (es) El uso de l-deprenyl para la fabricacion de un medicamento para el tratamiento de la enfermedad de cushing.
ATE271874T1 (de) Verwendung von inosine zur herstellung eines medikamentes zur stimulierung des axonwachstums von zns-neuronen
CY1107653T1 (el) Ενωσεις ειδικες για υποδοχεις α1, α2α και α3 αδενοσινης και χρησεις αυτων
HK1004257A1 (en) Use of droloxifene in the treatment of bone diseases
ZA976371B (en) Compounds with growth hormone releasing properties.
BR9103506A (pt) Novos usos de l-deprenil e composicoes para ele
EP0308197A3 (en) Method for stimulating the immune system
DE3784628D1 (de) Dermale behandlung von wurmerkrankungen der katze mit praziquantel.
GR3032224T3 (en) Therapeutic agent for threatened abortion.
US5547995B1 (en) Use of selegiline in veterinary medicine
AU653861B2 (en) Respiratory disease vaccine for cats
Van Jaarsveld et al. Immobilization and anaesthesia of spotted hyaenas, Crocuta crocuta.
ES2190499T3 (es) Uso de antagonistas de bradiquinina para la preparacion de medicamentos para el tratamiento y la prevencion de la enfermedad de alzheimer.
FR2708202B1 (fr) Implant biocompatible pour l'expression chez l'homme ou chez l'animal de substances déterminées.
IT1274012B (it) N-acetiltriptamine-2-sostituite, antagoniste ad elevata affinita' del recettore della melatonina
CA2170289A1 (en) A method of treating liver disease and like indications with vasodilating agents
RU93033105A (ru) Способ лечения острых вирусных заболеваний животных отряда псовых
ATE316373T1 (de) Conagenin zur behandlung von ulzerativer kolitis und/oder morbus crohn
IT1251993B (it) Composizioni farmaceutiche ad uso orale,a base di esteri di gangliosidi,per il trattamento di neuropatie del sistema nervoso periferico
ITRM920773A0 (it) Procedimento per tonificare e migliorare la capacita' del sistema muscolare umano a produrre lavoro e mezzi per la realizzazione di detto procedimento.
RU93000749A (ru) Способ лечения острой неспецифической бронхопневмонии молодняка крупного рогатого скота
RU92011168A (ru) Препарат для лечения гинекологических заболеваний
RU95119984A (ru) Способ лечения тяжелой сочетанной травмы
ES1030216Y (es) Cinturon terapeutico para el tratamiento de la impotencia.
RU96107031A (ru) Способ лечения хореи гентингтона

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 562705

Country of ref document: ES